XML 78 R63.htm IDEA: XBRL DOCUMENT v3.22.0.1
Investments - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2018
May 31, 2018
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2015
Schedule of Equity Method Investments [Line Items]            
Loss from related party equity method investment       $ 0 $ 31,702 [1]  
NantOmics            
Schedule of Equity Method Investments [Line Items]            
Number of Series A-2 units (shares) 9,088,362 564,779       169,074,539
Aggregate purchase price           $ 250,774
Ownership percentage in equity method investee (in percentage) 13.58%         14.28%
Difference between carrying amount and underlying equity, developed technologies           $ 28,195
Difference between carrying amount and underlying equity, reseller agreement           $ 14,382
Impairments on equity     $ 28,227      
Loss from related party equity method investment       $ 0 $ 31,702  
Investment in related party     $ 0      
[1] The statements for the year ended December 31, 2020 includes the Connected Care Business (see Note 4).